Nortem Biogroup (XPAR:MLBIO) Equity-to-Asset : 0.49 (As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Nortem Biogroup's Total Stockholders Equity for the quarter that ended in Dec. 2022 was €6.62 Mil. Nortem Biogroup's Total Assets for the quarter that ended in Dec. 2022 was €13.47 Mil. Therefore, Nortem Biogroup's Equity to Asset Ratio for the quarter that ended in Dec. 2022 was 0.49.

The historical rank and industry rank for Nortem Biogroup's Equity-to-Asset or its related term are showing as below:

XPAR:MLBIO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.49 Med: 0.52 Max: 0.54
Current: 0.49

During the past 2 years, the highest Equity to Asset Ratio of Nortem Biogroup was 0.54. The lowest was 0.49. And the median was 0.52.

XPAR:MLBIO's Equity-to-Asset is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.54 vs XPAR:MLBIO: 0.49

Nortem Biogroup Equity-to-Asset Historical Data

The historical data trend for Nortem Biogroup's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Equity-to-Asset Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Equity-to-Asset

0.54

0.49

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
Equity-to-Asset	0.54	0.49

Competitive Comparison of Nortem Biogroup's Equity-to-Asset

For the Packaged Foods subindustry, Nortem Biogroup's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Equity-to-Asset falls into.

Nortem Biogroup Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Nortem Biogroup's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	6.616	/	13.468
	=	0.49

Nortem Biogroup's Equity to Asset Ratio for the quarter that ended in Dec. 2022 is calculated as

Equity to Asset (Q: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	6.616	/	13.468
	=	0.49

Nortem Biogroup (XPAR:MLBIO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Nortem Biogroup Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines